PurpleAI Inc.

medical devices

About

PurpleAI became an independent company in October 2024 (in operations since 2019 as part of SK Group) and is a fast-growing medical AI pioneer transforming stroke care through intelligent automation and predictive foresight—enhancing workflow efficiency and diagnostic accuracy to drive better patient outcomes. PurpleAI is continuously expanding its Hyper Insight™ product portfolio across multiple imaging modalities and is pushing into multi-modal data-driven predictive analytics. Its upcoming flagship StrokeShieldAI is designed to anticipate and monitor high-risk complications following initial stroke treatment. By equipping clinicians with real-time foresight, StrokeShieldAI enables earlier intervention, mitigates adverse outcomes, and sets a new standard for stroke care.

Technologies

GmailGoogle AppsAmazon AWSMobile Friendly

Keywords

ai stroke detectionfdacleared ai samdemergency stroke triageai for community hospitalstelestroke ai solutionspacs integration aiai samd platform integrationclinical decision support aiaidriven radiologyremote stroke diagnosisaipowered emergency responseautomated stroke analyticsaienhanced ct analysisscalable ai samdai radiology workflow optimizationaienabled stroke screeningdigital stroke assessment aiaidriven emergency radiologyaipowered acute stroke careradiological computerassisted triageichmedical equipment manufacturingmedical and diagnostic laboratoriesai clinical diagnostic supportai-powered diagnostic supportai in high-volume clinical settingsmedical imaging aimedical image visualizationbrain ct scan analysisai triage software

Location

Seoul, Incheon, South Korea

Related Companies

Companies in the same industry